Cervix BT - 2016

SUMMARY DURING AND EARLY AFTER TREATMENT

During IGABT, the global health status / general QoL, physical and role functioning is substantially impaired. Although the functioning returns to patients’ baseline levels three months after treatment, it remains markedly lower compared to an age matched reference population. The transient decrease in functioning is paralleled by a transient increase in patient reported treatment-related symptoms, notably fatigue syndrome, diarrhea, urinary frequency and nausea. definitive radio(chemo)therapy with

Kirchheiner et al. Gyn Oncol 2014